We enhance your current prevention protocol with the right combination of interventions, delivering continous protection for your patients' most high-risk areas: the sacrum, heel and head. Portable and versatile, these interventions can be used to reduce risk at every point of care.
Pressure ulcers associated with medical devices including, restrictive dressings, tracheostomy and ventilators may account for up to one third of pressure ulcers in hospitalised adult patients
The Mölnlycke Z-Flo™ Fluidised positioner can help protect the patient by redistributing pressure to the neck and shoulders. They can also be moulded away from delicate areas of anatomy such as the ears.
This is where pressure ulcers most frequently occur
We offer clinically proven dressings that are specially designed to protect the sacral area, Mepilex® Border Sacrum is the only dressing backed by three randomised control trials
Its unique construction is scientifically proven to help minimise the effect of extrinsic risk factors
After the sacrum, the heel is the second most common site for pressure ulcers
Our solution includes Mepilex® Border Heel, clinically proven to protect the skin from damage caused by pressure, shear and friction*,
NICE Medtech Innovation Briefing
In October 2017 the UK National Institute for Health and Care Excellence (NICE) has issued a Medtech Innovation Briefing (MIB) on the Mölnlycke Mepilex® Border dressings for preventing pressure ulcers.
NICE Medtech Innovation Briefings (MIBs) are designed to support NHS and social care commissioners and staff who are considering using new medical devices and other medical or diagnostic technologies. The information provided includes a description of the technology, how it is used and its potential role in the care pathway.
MIBs are commissioned by NHS England and produced in support of the NHS 5 Year Forward View, specifically as one of a number of steps which will accelerate innovation in new treatments and diagnostics. NICE is scheduled to review their ‘Pressure Ulcers: prevention and management guidance’ in 2018.